ABCann heißt jetzt VIVO Cannabis - Älteste Beiträge zuerst (Seite 32)
eröffnet am 08.10.18 15:59:14 von
neuester Beitrag 22.12.22 14:57:01 von
neuester Beitrag 22.12.22 14:57:01 von
Beiträge: 361
ID: 1.290.066
ID: 1.290.066
Aufrufe heute: 0
Gesamt: 25.438
Gesamt: 25.438
Aktive User: 0
ISIN: CA92845J1049 · WKN: A2JR3J
0,0120
EUR
-22,08 %
-0,0034 EUR
Letzter Kurs 04.04.23 Tradegate
Werte aus der Branche Pharmaindustrie
Wertpapier | Kurs | Perf. % |
---|---|---|
1,2000 | +471,16 | |
13,110 | +38,44 | |
6,5000 | +27,45 | |
1,2100 | +21,00 | |
48,25 | +19,94 |
Wertpapier | Kurs | Perf. % |
---|---|---|
24,050 | -12,55 | |
4,0300 | -12,96 | |
6,2600 | -14,25 | |
3,8500 | -14,45 | |
36,70 | -22,87 |
VIVO Enters into Two Agreements with Medical Cannabis by Shoppers™
https://www.newswire.ca/news-releases/vivo-enters-into-two-a…
Habe Vivo IR mal mit folgendem Text angeschrieben (Michael Bumby parallel); schauen wir mal, ob sie sich melden
Dear Michael
i hope this email finds you well.
First of all thanks for your excellent work in growing Vivo to the size and product scope we are currently seeing.
I'm the owner of xxx shares of Vivo and would be grateful for the clarification of some issues I had with your presentations and valuations I found in the web:
1. Internal capacity
- is your internal growing capacity 5.000 or 12.000 kg (both numbers can be found in your company presentation?
- Can the capacity x price per gramm be used as a proxy of your revenues for the current year (assuming sales makes a good job ? I.e.: assuming a capacity of 12.000 kg would give us revenues of 84.000.000m Can$, gramm price 7 Can$?
2. Valuation
- as Vivo is one of the key players in the market and growing with substantial rates valuation of peers is about 20-30 x revenues which would indicate a share price between 2 and 3 Can$.
- in your current slide deck you are using multipliers between 2 and 3 for the revenue of your peers - which one is the right metric (it is obvious that valuations between 70 and 200 x revenues should not be considered realistic).
3. In terms of revenues what are your growth plans for 2020, 2021 and 2022
4. When do you expect German import licence
Thanks in advance for a reply and best regards from Germany, Munich
Sylvia
Dear Michael
i hope this email finds you well.
First of all thanks for your excellent work in growing Vivo to the size and product scope we are currently seeing.
I'm the owner of xxx shares of Vivo and would be grateful for the clarification of some issues I had with your presentations and valuations I found in the web:
1. Internal capacity
- is your internal growing capacity 5.000 or 12.000 kg (both numbers can be found in your company presentation?
- Can the capacity x price per gramm be used as a proxy of your revenues for the current year (assuming sales makes a good job ? I.e.: assuming a capacity of 12.000 kg would give us revenues of 84.000.000m Can$, gramm price 7 Can$?
2. Valuation
- as Vivo is one of the key players in the market and growing with substantial rates valuation of peers is about 20-30 x revenues which would indicate a share price between 2 and 3 Can$.
- in your current slide deck you are using multipliers between 2 and 3 for the revenue of your peers - which one is the right metric (it is obvious that valuations between 70 and 200 x revenues should not be considered realistic).
3. In terms of revenues what are your growth plans for 2020, 2021 and 2022
4. When do you expect German import licence
Thanks in advance for a reply and best regards from Germany, Munich
Sylvia
VIVO:
VIVO Cannabis Inc sieht in Britisch-Kolumbien eine große Nachfrage nach seinem Fireside X Shatter.
https://factsaboutcbd.org/vivo-cannabis-inc-otcmktsvvcif-see…
VIVO Cannabis Inc sieht in Britisch-Kolumbien eine große Nachfrage nach seinem Fireside X Shatter.
https://factsaboutcbd.org/vivo-cannabis-inc-otcmktsvvcif-see…
VIVO will release its second quarter 2020 results on Friday, August 14, 2020, after the close of markets.https://www.newswire.ca/news-releases/vivo-cannabis-to-host-…
Beitrag zu dieser Diskussion schreiben
Investoren beobachten auch:
Wertpapier | Perf. % |
---|---|
+0,17 | |
+0,43 | |
-2,00 | |
0,00 | |
+9.900,00 | |
-2,67 | |
0,00 | |
-0,42 | |
0,00 | |
-3,92 |
Meistdiskutiert
Wertpapier | Beiträge | |
---|---|---|
76 | ||
61 | ||
60 | ||
36 | ||
28 | ||
27 | ||
17 | ||
15 | ||
13 | ||
12 |